SCDM CCDM Exam With Confidence Using Practice Dumps

RACIis aproject management and governance frameworkused to defineroles and responsibilitieswithin a project. Each letter represents a distinct role type:

Responsible (R):The person(s) who perform the work or execute the task.

Accountable (A):The individual ultimately answerable for the task’s completion and success (only one per activity).

Consulted (C):Subject matter experts who provide input or guidance before decisions are made.

Informed (I):Individuals kept up to date on progress or outcomes but not directly involved in execution.

The RACI model ensuresclarity in ownership and accountability, preventing duplication of effort or responsibility confusion. It is a key component of theGCDMP (Chapter: Project Management in Data Management)for ensuring clear delegation and communication within clinical data management teams.

Hence,option Dis correct.

Reference (CCDM-Verified Sources):

SCDM GCDMP, Chapter: Project Management in Data Management, Section 5.1 – Roles, Responsibilities, and RACI Matrices

Project Management Institute (PMI) Framework – Responsibility Assignment Matrices (RACI)

ICH E6(R2) GCP, Section 5.1.1 – Defined Roles and Quality Oversight Responsibilities

Regulatory agencies such as theFDAandICHrequire thatelectronic data be retained in a format that preserves audit trails and traceability.

While PDF images (option C) provide a static representation of data, they do not preserve theunderlying audit trail(i.e., who changed what, when, and why). TheASCII data files with corresponding audit trails(option D) provide complete transparency and comply with21 CFR Part 11andGCDMParchival standards.

Option A(storing computers) is unnecessary and impractical, andOption B(paper source documents) are site records, not system archives.

Hence,option Dis correct —ASCII data files with audit trailsmeet traceability and compliance standards.

Reference (CCDM-Verified Sources):

SCDM GCDMP, Chapter: Database Lock and Archiving, Section 5.4 – Archival Formats and Audit Trail Retention

ICH E6(R2) GCP, Section 5.5.3 – Data Integrity, Audit Trails, and Record Retention

FDA 21 CFR Part 11 – Electronic Records; Audit Trail and Retention Requirements

To identifysite variability in eligibility screening, the most effective approach is toplot eligibility rate by site. This allows visual detection of differences in how well each site screens subjects according to protocol-defined inclusion and exclusion criteria.

TheGCDMP (Chapter: Data Quality Assurance and Metrics)emphasizes the importance of graphical analysis for identifying anomalies and site-level performance variability. By plotting the eligibility rate by site, data managers and clinical operations teams can quickly identify outliers—sites that screen too many or too few eligible subjects—indicating potential training issues, misunderstanding of inclusion/exclusion criteria, or even possible protocol deviations.

While summarizing screening rate (B) provides useful numeric data, it lacks visual comparability. Listing waivers (A) or enrollment counts (C) provide limited insights intoeligibility consistency.

Therefore,option D—Plot eligibility rate by site—is the best analytic and visualization practice to assess site variability in screening outcomes.

Reference (CCDM-Verified Sources):

SCDM GCDMP, Chapter: Data Quality Assurance and Control, Section 6.1 – Use of Metrics and Graphical Review for Site Performance

ICH E6(R2) GCP, Section 5.18.4 – Identification of Systematic or Site-Specific Issues